Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shield Thera (STX)

Price 2.70p on 31-01-2025 at 17:30:01
Change 0.10p 3.7%
Buy 2.80p
Sell 2.60p
Buy / Sell STX Shares
Last Trade: Buy 333,333.00 at 2.80p
Day's Volume: 1,741,134
Last Close: 2.80p
Open: 2.70p
ISIN: GB00BYV81293
Day's Range 2.80p - 2.80p
52wk Range: 1.075p - 6.20p
Market Capitalisation: £29m
VWAP: 2.705791p
Shares in Issue: 1,042m

Recent Trades History Shield Thera (STX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 333,333 2.80p Ordinary
16:39:48 - 31-Jan-25
Buy* 100,000 2.80p Suspected BUY Trade
16:35:06 - 31-Jan-25
Buy* 264,025 2.7255p Ordinary
16:29:42 - 31-Jan-25
Buy* 50,000 2.735p Ordinary
16:27:15 - 31-Jan-25
Sell* 11,924 2.645p Ordinary
16:22:58 - 31-Jan-25
Buy* 256,951 2.7227p Ordinary
16:22:22 - 31-Jan-25
Buy* 6,994 2.7175p Ordinary
16:08:23 - 31-Jan-25
Buy* 892 2.80p SI Trade
15:56:44 - 31-Jan-25
Sell* 384,409 2.6014p Ordinary
15:12:26 - 31-Jan-25
Buy* 30,000 2.7375p Ordinary
15:07:40 - 31-Jan-25

Share Price History for Shield Thera

Time period:
to
Date Open High Low Close Volume

Share News for Shield Thera

EXECUTIVE CHANGES: Smithson changes chairs; British Land taps new COO

28th Jan 2025 13:43

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced in the past week and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

17th Dec 2024 13:37

Read More

Shield Therapeutics to raise USD10.0 million via AOP subscription

6th Dec 2024 14:35

(Alliance News) - Shield Therapeutics PLC on Friday said it intends to raise USD10.0 million via a share subscription, and launched a retail offer to raise a further GBP1.0 million. Read More

Shield Therapeutics shares up on strong October sales

21st Nov 2024 14:22

(Alliance News) - Shield Therapeutics PLC on Thursday said it remains on track to meet its full-year revenue covenant target following strong sales of its iron deficiency treatment. Read More

Shield Therapeutics shares slide as it expands financing arrangement

29th Oct 2024 14:34

(Alliance News) - Shield Therapeutics PLC on Tuesday said it has strengthened its financial foundation in the hope of becoming cash flow positive by the end of 2025. Read More

FTSE 100 Latest
Value8,673.96
Change27.08

Login to your account

Forgot Password?

Not Registered